Keating Financial Advisory Services’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Keating Financial Advisory Services's EW Position: Q2 2026 in Review
Keating Financial Advisory Services increased its Edwards Lifesciences (EW) stake by 22% in Q2 2026, buying an estimated $6.62K and bringing the position to 431 shares worth $39K. The position accounts for 0.01% of the portfolio, ranked #753.
Keating Financial Advisory Services first reported a position in EW in Q4 2025 and has held it in 3 quarters since. 1,328 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Keating Financial Advisory Services held 431 shares of Edwards Lifesciences worth $39K as of Q2 2026.
- Keating Financial Advisory Services bought 79 Edwards Lifesciences shares in Q2 2026, an estimated $6.62K.
- Edwards Lifesciences made up 0.01% of Keating Financial Advisory Services's portfolio in Q2 2026, its #753 holding.
- Keating Financial Advisory Services first reported a position in Edwards Lifesciences in Q4 2025 and has held it in 3 quarters since.
- 1,328 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.